Poland· PL-100097278
ProHance
A gadobutrol product containing gadoteridolum, registered in Poland by Bracco Imaging Deutschland GmbH. The same ATC class is registered in 16 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Gadobutrol is registered in 16 of 19 countries.
Countries holding a registration under ATC V08CA09 (gadobutrol), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 9 of them publish a price we can compare per daily dose
Gadobutrol · ATC V08CA09
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Gadoteridolum
- Manufacturer
- Bracco Imaging Deutschland GmbH
- Country
- Poland (PL)
- ATC code
- V08CA09
- ATC class
- Gadobutrol
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 18
- gtin05909990832187
- gtin05909990832019
- gtin05909990832026
- gtin05909990832033
- gtin05909990832040
- gtin05909990832170
- gtin05909990832057
- gtin05909990832071
- gtin05909990832088
- gtin05909990832095
- gtin05909990832101
- gtin05909990832064
- gtin05909990832118
- gtin05909990832125
- gtin05909990832132
- gtin05909990832149
- gtin05909990832156
- gtin05909990832163
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
22 interactions on record for gadobutrol.
Graded by severity as the source publishes them — 22 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Gadobutrol · interactions on record
22 records
- 22 moderate
Most severe, free to view
- PindololC07AA03moderate
- PropranololC07AA05moderate
- TimololC07AA06moderate
- SotalolC07AA07moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Gadobutrol in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumProhance 279.3 mg/mlBracco Imaging Deutschland
- CzechiaPROHANCEBracco Imaging Deutschland GmbH, Konstanz
- SpainPROHANCE 279,3 mg/ml SOLUCION INYECTABLEBracco International B.V.
- SwedenProHance 279,3 mg/ml Injektionsvätska, lösningBracco International BV
- NetherlandsProHance, oplossing voor injectie 279,3 mg/ml = 0,5 molairBracco Imaging Deutschland GmbH
- NorwayProHanceBracco International B.V.
- SwitzerlandProHance 0.5 mmol/ml, soluzione iniettabile (flacone)Bracco Suisse SA
- United KingdomProHance 0.5mmol/ml solution for injection 10ml pre-filled syringesBracco UK Ltd
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Prohance
- Belgium · Prohance
- Czechia · Prohance
- Germany · Prohance
- Denmark · Prohance
- Estonia · Prohance
- Spain · Prohance
- Finland · Prohance
- France · Prohance
- United Kingdom (Northern Ireland) · Prohance
- Greece · Prohance
- Croatia · Prohance
- Hungary · Prohance
- Ireland · Prohance
- Italy · Prohance
- Lithuania · Prohance
- Luxembourg · Prohance
- Latvia · Prohance
- Netherlands · Prohance
- Norway · Prohance
- Portugal · Prohance
- Romania · Prohance
- Sweden · Prohance
- Slovenia · Prohance
- Slovakia · Prohance
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/346a4934-e6a3-4740-a1bb-c594cd107a99 GET /v1/drugs/346a4934-e6a3-4740-a1bb-c594cd107a99?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "279,3 mg/ml",
"packaging": "05909990832170 ¦ Rp ¦ 13690\n5 amp.-strzyk. 15 ml\n05909990832187 ¦ Rp ¦ 13691\n5 amp.-strzyk. 17 ml\n05909990832019 ¦ Rp ¦ 16304\n1 fiol. 5 ml\n05909990832026 ¦ Rp ¦ 16306\n1 fiol. 10 ml\n05909990832033 ¦ Rp ¦ 16307\n1 fiol. 15 ml\n05909990832040 ¦ Rp ¦ 16308\n1 fiol. 20 ml\n05909990832057 ¦ Rp ¦ 16309\n1 fiol. 50 ml\n05909990832071 ¦ Rp ¦ 16310\n5 fiol. 10 ml\n05909990832088 ¦ Rp ¦ 16311\n5 fiol. 15 ml\n05909990832095 ¦ Rp ¦ 16314\n5 fiol. 20 ml\n05909990832101 ¦ Rp ¦ 16315\n10 fiol. 50 ml\n05909990832064 ¦ Rp ¦ 16316\n5 fiol. 5 ml\n05909990832118 ¦ Rp ¦ Skasowane ¦ 16317\n1 amp.-strzyk. 5 ml\n05909990832125 ¦ Rp ¦ 16318\n1 amp.-strzyk. 10 ml\n05909990832132 ¦ Rp ¦ 16319\n1 amp.-strzyk. 15 ml\n05909990832149 ¦ Rp ¦ 16320\n1 amp.-strzyk. 17 ml\n05909990832156 ¦ Rp ¦ Skasowane ¦ 16321\n5 amp.-strzyk. 5 ml\n05909990832163 ¦ Rp ¦ 16323\n5 amp.-strzyk. 10 ml",
"substance": "Gadoteridolum 279.3 mg",
"common_name": "Gadoteridolum",
"pl_product_id": "100097278",
"pozwolenie_nr": "08320",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about gadobutrol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.